04.04.2013 Views

INTRODUCTION Granulomatous inflammation is a distinctive ...

INTRODUCTION Granulomatous inflammation is a distinctive ...

INTRODUCTION Granulomatous inflammation is a distinctive ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Patients with spinal cord sarcoidos<strong>is</strong> progress in four phases, which begin with a linear<br />

leptomeningeal pattern of enhancement and progress to a phase in which there <strong>is</strong> cord<br />

enlargement with faint enhancement or no enhancement. Enhancement then progresses but the<br />

cord begins to reduce in size until it reaches a final stage of atrophy without any enhancement.<br />

Although it <strong>is</strong> fairly evident that patients who present with cord atrophy will most likely not<br />

respond to steroid treatment, it <strong>is</strong> unclear whether the degree of enhancement plays a role in<br />

treatment response (Greg et al., 1999).<br />

Figure 21. Sarcoidos<strong>is</strong>. T1W gadolinium-enhanced sagittal MRI of the<br />

thoracic spinal cord showing focal contrast enhancement and expansion of the<br />

cord at T6–T7 level (arrowed). ( Zajicek et al., 1999)<br />

In general, resolution of lesions on MR imaging lags behind resolution of clinical symptoms. The<br />

role of MR imaging in neurosarcoidos<strong>is</strong> <strong>is</strong> to confirm clinical suspicion, establ<strong>is</strong>h subclinical<br />

d<strong>is</strong>ease, and document the response of pathologic lesions to treatment (Zylberberg et al., 2001).<br />

Neurophysiological Studies<br />

Evoked potential (EP) studies may be of value in supporting the diagnos<strong>is</strong> and monitoring the<br />

course of the d<strong>is</strong>ease. VEPs and brainstem auditory evoked potentials (BAEPs) tend to be<br />

abnormal in about one third of the patients with neurosarcoidos<strong>is</strong>. Somatosensory evoked<br />

potentials tend to show abnormalities less frequently. All 3 modalities of EPs can show<br />

abnormalities in patients before the appearance of clinical signs (Oksanen, 1986).<br />

EMG/nerve conduction studies can be used to confirm neuropathy or myopathy. The most<br />

character<strong>is</strong>tic electrodiagnostic finding <strong>is</strong> mononeuropathy multiplex, showing axonal<br />

degeneration and segmental demyelination. With treatment and clinical improvement, motor,<br />

sensory and mixed nerve conduction tend to improve. In cases of myopathy, the EMG shows<br />

myopathic potentials (Ando et al., 1985).<br />

Nuclear studies<br />

Gallium 67 citrate scans often are supportive when typical findings are lacking. Th<strong>is</strong> <strong>is</strong> especially<br />

true in neurosarcoidos<strong>is</strong> or uveit<strong>is</strong> when biopsy may not be feasible. Gallium 67 scanning may help<br />

demonstrate sites of <strong>inflammation</strong>. Positive scans secondary to increased uptake can identify<br />

asymptomatic lesions. Though the test can be positive in any inflammatory or neoplastic lesions,

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!